Zhejiang Yangli Pharmaceutical Technology Co., Ltd.

This early-stage study tests a new tablet called VB19055 in 86 healthy Chinese adults to see if it is safe and how the body processes it. The goal is to gather initial safety data for a potential new high blood pressure treatment. Participants will be randomly assigned to receive…